i transcribed from CC i am still learning and JP's way of speaking is (how should i say) characterized by "run on" sentences, so i must work harder to understand...
both interpretations (yours and Dew's) seem valid.
later in the CC JP spoke of not asking for exclusivity... it is my understanding that this means (that in combination studies), the company(s) could test their drug(s) w/ other drugs, not only w/ 283 and vice versa. correct?
News 
Market Data 
Discover 
AI
